Low‐Dose Tirzepatide for Obesity: Comparative Efficacy of 2.5 mg Versus 5 mg in Non‐Diabetic Japanese Adults

Michitaka Amioka, Hideyo Amioka, Hiroki Kinoshita, Akinori Sairaku, Yukiko Nakano

Open source

DOI
10.1111/dom.71162
Published
2026-07-28
Container
Diabetes, Obesity and Metabolism
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/dom.71162,
  title = {Low‐Dose Tirzepatide for Obesity: Comparative Efficacy of 2.5 mg Versus 5 mg in Non‐Diabetic Japanese Adults},
  author = {Michitaka Amioka and Hideyo Amioka and Hiroki Kinoshita and Akinori Sairaku and Yukiko Nakano},
  year = {2026},
  journal = {Diabetes, Obesity and Metabolism},
  doi = {10.1111/dom.71162},
  url = {https://doi.org/10.1111/dom.71162}
}

RIS

TY  - JOUR
TI  - Low‐Dose Tirzepatide for Obesity: Comparative Efficacy of 2.5 mg Versus 5 mg in Non‐Diabetic Japanese Adults
AU  - Michitaka Amioka
AU  - Hideyo Amioka
AU  - Hiroki Kinoshita
AU  - Akinori Sairaku
AU  - Yukiko Nakano
PY  - 2026
JO  - Diabetes, Obesity and Metabolism
DO  - 10.1111/dom.71162
UR  - https://doi.org/10.1111/dom.71162
ER  - 

APA

Amioka, M., Amioka, H., Kinoshita, H., Sairaku, A., & Nakano, Y. (2026). Low‐Dose Tirzepatide for Obesity: Comparative Efficacy of 2.5 mg Versus 5 mg in Non‐Diabetic Japanese Adults. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71162

Source records